Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

NSE : COHANCEBSE : 543064ISIN CODE : INE03QK01018Industry : Pharmaceuticals & DrugsHouse : Private

BSE1082.05-11 (-1.01 %)

PREV CLOSE ( ) 1093.05

OPEN PRICE ( ) 1119.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 8033

TODAY'S LOW / HIGH ( )1071.50 1119.95

52 WK LOW / HIGH ( )814.25 1359

NSE1083.35-13.65 (-1.24 %)

PREV CLOSE( ) 1097.00

OPEN PRICE ( ) 1090.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 1083.35 (1380)

VOLUME 211477

TODAY'S LOW / HIGH( ) 1072.95 1102.20

52 WK LOW / HIGH ( )815.05 1360

Chairman	Vivek Sharma
Managing Director	V Prasada Raju
Company Secretary	Kundan Kumar Jha
Non Executive Director	Pankaj Patwari Shweta Jalan
Independent Director	Jai Shankar Krishnan
Non Executive Independent Director	K G Ananthakrishnan Matangi Gowrishankar Vinod Rao UB Pravin Rao
Non Independent Director	Vinod Padikkal

Incorporation Year : 06-11 2018

Registered Office :

Address : 215 Atrium, C Wing, 8th Floor, 819-821,Andheri, Kurla Road, Chakala,Andheri (East), Chakala Midc Mumbai,
Maharashtra-400093 .

Phone : 022-61539999

Industry : Pharmaceuticals & Drugs

Listing : BSE,NSE